News summary
Development team for pharmaceutical
care models to be set up in Scotland The Royal Pharmaceutical
Society in Scotland and the Scottish Executive are to set up a pharmaceutical
care model scheme (PCMS) development team to design and implement PCMSs
for the whole of Scotland...[more]
Government seeks views on new regulatory council
of Health Professionals The Government has started public
consultations on a proposal to create a Council for the Regulation of
Health Professionals (CRHP). It does not consider the current arrangements
for the accountability of professions, including pharmacy, to be satisfactory...[more]
Old drugs for new variant CJD Mepacrine
and chlorpromazine, both of which have been available for many years,
could prove to be effective treatments for diseases caused by prions,
such as new variant Creutzfeldt-Jakob disease (nvCJD)...[more]
Co-enzyme Q10 hope for Huntington’s disease
Co-enzyme Q10 might be useful in preventing functional decline
in Huntington’s disease a new study shows. Researchers say that although
results are inconclusive, it is the first controlled trial to find a trend
towards a beneficial change in functional decline...[more]
Clopidogrel may improve outcome in acute coronary
syndrome Adding clopidogrel to standard aspirin therapy improves
outcome in patients with acute coronary syndromes, researchers have found...[more]
Moss launches Total Health pharmacy Moss
Pharmacy has launched a new store format — Total Health — which
the company says heralds the future of community pharmacy retailing...[more]
Three more POMs become pharmacy medicines Three
prescription medicines used to treat eczema and dermatitis, fungal infections
and migraine-related nausea and vomiting become pharmacy only (P) medicines
on 24 August 2001...[more]
Iron for ACE inhibitor-induced cough Iron
supplements might prevent angiotensin-converting enzyme (ACE) inhibitor-induced
dry cough, researchers in Korea suggest...[more]
Trials suggest benefit of donepezil in Alzheimer’s
Donepezil (Aricept) might be beneficial for people with early
Alzheimer’s disease for as long as a year, results of two studies
have indicated. In both trials, subjects were randomised to receive either
donepezil 10mg daily or placebo for one year...[more]
Role of inflammation in Alzheimer’s questioned
Doubts have been cast over the role of inflammation in Alzheimer’s
disease as a result of a study conducted in the Netherlands...[more]
Botulism leads to milk formula recall SMA
Nutrition is recalling two of its infant milk formula powders following
a recent case of infant botulism...[more]
PSNC examines impact of generics proposals The
Pharmaceutical Services Negotiating Committee, in association with the
National Pharmaceutical Association, has asked a firm of economics consultants
to study the effects that the Department of Health’s proposals for
changing the market for generic medicines might have on community pharmacies...[more]
A quarter of PCTs have pharmacists on board Pharmacists
have won places on nearly a quarter of the primary care trust executive
committees that have been confirmed by Secretary of State for Health,
Alan Milburn...[more]
Mawdsley offers window panels Mawdsley-Brooks
& Co Ltd is offering community pharmacies an opportunity to participate
in a window panel display programme promoting the advice offered by pharmacy
staff rather than specific product lines...[more]
Pharmacist voted local health group chairman
Chris Martin, a community pharmacist from St Davids, Pembrokeshire,
has been appointed chairman of Pembrokeshire Local Health Group, the third
pharmacist in Wales to achieve such a position...[more]
Average prescription cost falls The
average cost to the National Health Service in England of a general practice
prescription fell in real terms last year (2000) for the first time in
at least 10 years...[more]
NEWS IN BRIEF
Canadian cannabis trial GW Pharmaceuticals,
which is developing cannabis-based medicines, has started a clinical trial
in Canada to test the effectiveness of a cannabis extract sublingual spray
against chronic pain in multiple sclerosis and spinal cord injury patients.
|
